Yes, diphenoxylate-atropine is a controlled substance. The combination product, sold under the brand name Lomotil, is classified as a Schedule V controlled substance under federal law. This is the lowest level of controlled substance scheduling, meaning it requires a prescription but carries minimal abuse potential compared to higher-schedule drugs.
Why It’s a Controlled Substance
Diphenoxylate is the reason for the controlled classification. It’s a synthetic opioid, structurally related to meperidine (a potent pain medication). While it’s primarily used to slow gut motility and treat diarrhea rather than to relieve pain, it still activates opioid receptors. At standard doses, diphenoxylate doesn’t cross into the brain as readily as typical opioids, so it produces little to no euphoria. But at higher doses (roughly 40 to 60 mg, well above the therapeutic range), it can produce opioid-like euphoric effects. That potential for misuse at high doses is what keeps it on the controlled substances list.
When diphenoxylate is formulated by itself, without atropine, it carries a much stricter classification: Schedule II, the same category as oxycodone and fentanyl. The addition of atropine is what drops it down to Schedule V.
What the Atropine Is For
Each tablet contains 2.5 mg of diphenoxylate and just 0.025 mg of atropine sulfate. That tiny amount of atropine has no real therapeutic effect at normal doses. It’s there purely as an abuse deterrent. If someone takes large quantities of the medication trying to get an opioid high, the atropine builds up and causes extremely unpleasant side effects: rapid heart rate, flushed skin, dry mouth, difficulty urinating, and overheating. These anticholinergic effects make taking excessive doses deeply uncomfortable, which discourages misuse and is the reason the combination earns a lower schedule than diphenoxylate alone.
What Schedule V Means in Practice
Schedule V is the least restrictive tier of controlled substances. You still need a prescription to get diphenoxylate-atropine, and pharmacies track it differently than non-controlled medications. Your pharmacist may ask for identification, and refill policies can be slightly stricter than for a standard prescription. That said, it’s far less regulated than Schedule II drugs, which often require a new written prescription each time and have tighter limits on quantity.
Some states have their own rules on top of the federal classification. A few states impose additional requirements on Schedule V drugs, such as limiting the number of refills or requiring the prescriber’s DEA number on the prescription. Your pharmacy will handle the specifics based on where you live.
How It Compares to Over-the-Counter Options
Loperamide (Imodium) is the most common comparison. Both drugs are structurally similar, both slow down the intestines by activating opioid receptors in the gut, and both are piperidine compounds related to opioids. The key difference is that loperamide barely crosses into the brain even at high doses, producing very little euphoria. That’s why loperamide is available over the counter with no controlled substance designation, while diphenoxylate requires a prescription.
In clinical trials, both drugs effectively control chronic diarrhea. Loperamide actually performed slightly better at reducing stool frequency and improving consistency, even at a 2.5-fold lower dose. For most people with routine diarrhea, loperamide is the simpler and more accessible choice. Diphenoxylate-atropine is typically reserved for cases where over-the-counter options haven’t worked well enough.
Safety Concerns Worth Knowing
Because diphenoxylate is an opioid, overdose can cause dangerously slow breathing, extreme drowsiness, and coma. The atropine component adds its own layer of toxicity at high doses, causing rapid heartbeat, flushed skin, hallucinations, and seizures. Overdose symptoms can be delayed by several hours, which makes accidental ingestion particularly dangerous since someone may appear fine at first.
Children are at the highest risk. The FDA contraindicates diphenoxylate-atropine in children under 6 because even small amounts can cause severe respiratory depression, coma, permanent brain damage, or death. The medication is only approved for patients 13 and older. If you have this medication at home, storing it securely and out of children’s reach is critical. Children with Down syndrome are especially sensitive to the atropine component and may develop symptoms like high body temperature, rapid heart rate, and urinary retention more easily.
Overdose symptoms in anyone include slow or stopped breathing, pounding or rapid heartbeat, extreme drowsiness, constipation, dry mouth, flushed skin, pupil changes, restlessness, and difficulty urinating. Because the effects can appear hours after ingestion, any suspected overdose warrants immediate medical attention even if the person looks fine initially.